Follow up EMA and EORTC multi-stakeholder workshop on soft tissue and bone sarcoma, Online, European Medicines Agency, Amsterdam, the Netherlands, 24 May 2024

Follow up EMA and EORTC multi-stakeholder workshop on soft tissue and bone sarcoma, Online, European Medicines Agency, Amsterdam, the Netherlands, 24 May 2024

Human medicines European public assessment report (EPAR): Tizveni, tislelizumab, Date of authorisation: 19/04/2024, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Tizveni, tislelizumab, Date of authorisation: 19/04/2024, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Evicel, human fibrinogen,human thrombin, Date of authorisation: 05/10/2008, Revision: 18, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Evicel, human fibrinogen,human thrombin, Date of authorisation: 05/10/2008, Revision: 18, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Date of authorisation: 15/04/2005, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Date of authorisation: 15/04/2005, Revision: 35, Status: Authorised

ICH reflection paper on pursuing opportunities for harmonisation in using real-world data to generate realworld evidence, with a focus on effectiveness of medicines

ICH reflection paper on pursuing opportunities for harmonisation in using real-world data to generate realworld evidence, with a focus on effectiveness of medicines

European Shortages Monitoring Platform Essentials and Industry Reporting Requirements, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 June 2024, 10:00 (CEST) to 24 June 2024, 12:30 (CEST)

European Shortages Monitoring Platform Essentials and Industry Reporting Requirements, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 June 2024, 10:00 (CEST) to 24 June 2024, 12:30 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness